- Report
- January 2026
- 191 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- January 2026
- 190 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- January 2026
- 197 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- January 2026
- 195 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- January 2026
- 189 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- January 2026
- 194 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- January 2026
- 188 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- January 2026
- 185 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- January 2026
- 198 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- January 2026
- 189 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- January 2026
- 193 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- January 2026
- 180 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- January 2026
- 181 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- January 2026
- 188 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- January 2026
- 181 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- January 2026
- 184 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- January 2026
- 186 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- January 2026
- 195 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- January 2026
- 192 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- January 2026
- 195 Pages
Global
From €3439EUR$3,939USD£2,978GBP

The Immunosorbent Assay (ELISA) market is a segment of the Diagnostics industry that focuses on the detection and quantification of antigens and antibodies in biological samples. ELISA is a laboratory technique used to detect and measure the presence of specific proteins, hormones, and other molecules in a sample. ELISA tests are used to diagnose a variety of medical conditions, including autoimmune diseases, allergies, and infections. ELISA tests are also used to detect the presence of drugs and toxins in the body.
The ELISA market is driven by the increasing prevalence of chronic diseases, the growing demand for point-of-care testing, and the increasing demand for personalized medicine. The market is also driven by technological advancements in the field of diagnostics, such as the development of automated ELISA systems.
Some of the major companies in the ELISA market include Abbott Laboratories, Bio-Rad Laboratories, Thermo Fisher Scientific, Merck KGaA, and Roche Diagnostics. Show Less Read more